+: presence of genetic lesions; -: absence of genetic lesions; loss: homozygous deletion or hemizygous mutation; amp: copy number difference between EGFR and HGF > 5; del: copy number < 1.5; mut: mutation; n.a.: not available. a: gene expression profile (GEP) subtype according to the Verhaak's signature (Verhaak et al., 2010) ; CL: classical; MES: mesenchymal; PN: proneural. 
Appendix Methods

Neurosphere derivation from human patients and culture
Surgical samples were obtained from consecutive primary GBM provided by the Fondazione IRCCS Istituto Neurologico C. Besta, according to a protocol approved by the institutional Ethical Committee. All Patients signed an informed consent. NS were derived as described (De Bacco et al., 2012) , and plated at clonal density in standard NS medium containing human recombinant bFGF (20 ng/ml) and EGF (20 ng/ml). For in vitro experiments, NS were kept in a modified medium with a lower concentration of EGF and bFGF (10 ng/ml), and supplemented with human recombinant HGF (10 ng/ml). Both media sustain the same NS proliferation rate (Appendix Fig   S9A) . NS-derived pseudodifferentiated cells were obtained by culture in medium deprived of growth factors and supplemented with 2% FBS, in pro-adherent culture dishes, for 7 days. GBM cell lines (SNB19, U251 and U87MG), human astrocyte cell lines (NHA, SVG), GTL16, A2780, A549 and EBC1 cell line were kept in culture according to manufacturer's instructions (ATCC).
For immortalized cell lines, a passage below 15 was used.
NS irradiation and treatment with inhibitors
NS were irradiated with a 200 kV X-ray blood irradiator (Gilardoni), and a 1 Gy/min dose-rate. In some experiments, HGF (20 ng/ml) was added to standard medium 1 h before irradiation. For MET targeting, the kinase inhibitors JNJ38877605 (500 nM, Janssen Pharmaceutica) (De Bacco et al., 2011) , PHA665752 (500 nM; Tocris Cookson Ltd), or Crizotinib (500 nM, Sequoia Research Products) were added to cells 2 h before irradiation; the monovalent monoclonal MET antibody MvDN30 (28µg/ml) was added 24 h before (Pacchiana et al., 2010) . 
Lentiviral transduction of NS
NS were dissociated to single-cell suspensions, and 10 5 cells were transduced in standard medium with lentiviral particles expressing a bicistronic luciferase-GFP construct (CMV-Luc-IRES-GFP, (Vigna et al., 2002) (an average of 95% and 99% was obtained).
Xenografts models
All animal procedures were approved by the internal Ethical Committee for Animal Experimentation (FPRC-CESA) and by the Italian Ministry of Health. Mus musculus, female NOD.CB17-Prkdc scid /NcrCr mice (Charles River Laboratories) were kept and manipulated under pathogen-free conditions. In details, mice were housed in filtered bottomed, individually sterilized and ventilated cages. Every cage contained a maximum of 6 mice and suitable amounts of sterilized food, water and bedding. Cages were changed weekly to prevent the introduction of minimalinoculating doses of opportunistic or commensal organisms in the cage environment, and mice were manipulated under a laminar-flow hood.
To generate xenograft models, neurospheres were dissociated into single-cell suspensions, and injected subcutaneously or orthotopically into 6-8 weeks old female NOD-SCID mice. Accordingly, at least 6 mice/group were used.
Nucleic acid extraction
From NS, nucleic acids were extracted as follows: genomic DNA (gDNA), using the Wizard® Genomic DNA Purification kit (Promega); total RNA, using the mRNeasy Mini kit (Qiagen), according to manufacturer's instructions. Extracted purified nucleic acids were quantified with Nanodrop ND1000 (Thermo Scientific).
Gene sequencing and evaluation of copy number alteration
TP53 and PTEN purified gDNAs were amplified using Platinum® Taq DNA Polymerase (Invitrogen) and specific primer pairs (De Bacco et al., 2012) . PCR products were purified using polysomy, EGFR copy number was normalized against the copy number of a gene mapped on chr7
and usually not amplified (HGF), and defined amplified when EGFR/HGF copy number was > 5.
Reported values are the mean ± SEM of two independent experiments in triplicate.
Microarray analysis
Gene expression profiling and NS classification according to Verhaak's subtypes (Verhaak et al., 2010 ) was performed as previously described (De Bacco et al., 2012) .
Real-Time PCR
500 ng of purified mRNA was reverse-transcribed using High Capacity Reverse Transcriptase kit (Applied Biosystem) according to manufacturer's instructions. Real-time PCR was performed using commercially available primers and probe sets for MET, RAD51, and SOX2 with TaqMan PCR Master Mix (Applied Biosystems), and ABI PRISM 7900HT sequence detection system. Expression levels were normalized against endogenous controls (β2 microglobulin or β-actin) and non-treated cells were used as calibrator. Reported values are the mean ± SEM of at least two independent experiments in triplicate.
Comet assay
To evaluate DNA double strand breaks (DSBs) induced by IR, Neutral Comet Assay (Trevigen) was used according to manufacturer's instructions. For each experimental point, 103 cells were used. Comet slides were examined by eye at 10× magnification under a fluorescence microscope.
Measurements of DNA damage was evaluated semi-quantitatively using the following definitions:
nucleoid with no tail: undamaged DNA; nucleoid with short tail (short comet): modest DNA DSBs; nucleoid with long tail (long comet): severe DNA DSBs (representative images of nucleoid with no tail, and short and long comet were shown in Appendix Fig S9B) . Experiments were repeated at least twice in duplicate, and a representative experiment was shown.
Western blotting
Protein expression and phosphorylation were analyzed in whole-cell lysates solubilized in boiling
Laemmli buffer, or in cytoplasmic and nuclear portions fractionated as previously described ( 
Immunophenotypical analysis and Fluorescence-Activated Cell Sorting
NS were dissociated and resuspended in PBS 3% BSA at a concentration of 2 × 10 5 cells/100 µl.
The following antibodies were used: phospho-H2AX-FITC (Ser139; #17-344, Merck Millipore);
Olig2-Alexa-Fluor 488 (#MABN50A4, Merck Millipore); HGF R/c-MET (clone 95106; MAB3582, R&D System), conjugated by the manufacturer with PE or APC, or in house with PECy7, according to manufacturer's instructions (R&D System). The three antibodies display comparable specificity (Appendix Fig S9C) . The % of positive cells was calculated by comparing unstained vs. stained cells in each sample, as to avoid bias associated with morphological, and ensuing autofluorescent, changes due to irradiation (Maecker and Trotter, 2006) . Before analysis, 
Cell cycle analysis
Cell cycle was analyzed according to standard procedures. Briefly, 10 6 cells were fixed with 70%
Ethanol overnight at -20°C, stained with propidium iodide (50 µg/ml) in RNaseA solution (DNAcon3 kit ConsulTS) for 3 h at 4°C in the dark, and analyzed by flow-cytometry as above. Data are the mean ± SEM of at least two independent experiments.
Cell viability and caspase activation assays
To assess NS viability and apoptosis, ATP cell content and Caspase 3/7 activity were measured using Cell Titer Glo® and Caspase-Glo® 3/7 Assay (Promega) respectively, according to manufacturer's instructions. Cells were plated at clonal density (10 cells/µl) in 96-well plates, and treated as described 24 h after seeding (day 0). Cell viability and caspase 3/7 activity were measured using a GloMax 96 Microplate Luminometer (Promega). Data are reported with respect to non-treated cells as mean ± SEM of at least two independent experiments in quadruplicate.
Radiobiological clonogenic assay
Met high and Met neg cell subpopulations were sorted as described above and seeded as single cell/well. 24 h after sorting, cells were irradiated in the presence or in the absence of MET inhibitors, and then cultured for 14 days. The number of growing NS was counted, and the surviving fraction was calculated using the formula, modified from (Franken et al., 2006) : [(n° of NS formed after treatment) / (PE)] x 100, where PE (plating efficiency) is the percentage of NS in control conditions. The reported values are the mean ± SEM of two independent experiments.
Limiting dilution sphere forming assay in vitro
Limiting dilution sphere forming assay was performed to assess the frequency of GSC in NS established from original tumors, or in cells freshly dissociated from xenografts obtained by NS transplantation. Viable cells (trypan blue exclusion test) were plated into 96-well plates at decreasing concentrations (ranging from 150 cells/well to 1 cell/well). The number of growing NS was counted 14-21 days after seeding. Data were evaluated through the ELDA software (http://bioinf.wehi.edu.au/software/elda/) (Hu et al., 2009) , and reported as percentage of stem-like cells ± CI.
Serial transplantation assay
NS were irradiated in vitro (p0) as described above, and 24 h after irradiation 10 3 cells were resuspended in 100 µl v/v PBS/Matrigel, and subcutaneously injected in 4 mice (p1). Tumor formation was monitored once a week by caliper as described above. From p1 tumors, cells were dissociated as described above for human tumor specimens, and, when NS formed, 10 3 cells in 100
µl v/v PBS/Matrigel were subcutaneously injected in 6 mice (p2). From p2 tumors, cell isolation and NS formation was repeated as above, and cells were assessed by in vivo limiting dilution assay, by injecting 10, 10 2 , 10 3 , or 10 4 cells in 6 mice per condition (p3). Frequency of stem-like cells was calculated using ELDA software as above and reported as stem-like cells per 10,000 cells.
Limiting dilution assay in vivo
In vivo serial dilution tumor-propagating assay was performed to evaluate the relative frequency of GSCs in subcutaneous xenografts after radiosensitization treatment. Subcutaneous xenografts were 
Irradiation and radiosensitization of xenograft models
To establish treatment groups and to minimize the effect of subjective bias, mice with either subcutaneous tumors of approximately 400 mm 3 , or orthotopic tumors with a BLI average radiance signal of 7 × 10 5 p/s/sr/cm 2 , were randomized and group allocated by LAS software (Baralis et al., 2012) . During randomization and generation of the experimental arms, mice were excluded from the studies if the tumor volume was indicated as outlier by LAS software. No tumor formation, due to technical problems during neurosphere injections, was also considered as a criterion of exclusion. In the orthotopic model, mice were euthanized at day 62 (at the onset of neurological symptoms in the control group). Explanted brains were immediately analyzed for GFP signal detection (e x 465 nm, e m 520 nm; IVIS® SpectrumCT). Data were collected by A.D.A. with no blinding.
Immunofluorescence analysis
Dissociated neurospheres were seeded on poly-lysine coated slides, treated as indicated, fixed and incubated with rabbit polyclonal anti-p21 (1:50 in PBS/1% BSA, Cell Signaling Technology)
antibodies. Xenograft specimens were embedded in OCT, cryo-sectioned at 10 µm, and incubated with mouse monoclonal anti-Met DO-24 antibodies (1:100 in PBS/1% BSA) (Prat et al., 1998) .
Anti-mouse Alexa-Fluor 555 (1:1000, Molecular Probes by Life Technologies) was used as secondary antibody. Nuclei were counter-stained with DAPI, according to standard protocols. in two sections from each tumor, for a total of 3 mice/group, were counted.
Association of MET expression with disease free and overall survival in public dataset
MET mRNA expression data were obtained from the public TCGA GBM dataset available on cBioPortal (http://www.cbioportal.org), selecting the provisional dataset (June 2015, Agilent microarray data, n = 401), and applying an mRNA Z-score threshold of ± 2. Disease-free and overall survival curves were obtained with the cBioPortal software using the Kaplan-Meier method (Cerami et al., 2012; Gao et al., 2013) .
Collection of matched primary and recurrent human GBMs.
Surgical samples were derived from primary and matched recurrent GBMs surgically removed at the Spedali Civili di Brescia, according to a protocol approved by the institutional Ethical 
